Riskpilot← Back to searchSign inGet full accessSILKO AS
ASActiveOrg 998751608Medical City Lørenveien 68, 0585 OsloGeneral medical practice activities · NACE 8621Est. 20120 employees
Revenue 2024
NOK 2,5M
+1139% vs 2023
EBITDA margin
61.2%
+659% vs 2023
Equity ratio
24.9%
Financial strength
Net profit 2024
NOK 1,2M
+636% vs 2023
| Revenue | NOK 2,5M | +1139% |
| EBITDA | NOK 1,5M | +659% |
| Net profit | NOK 1,2M | +636% |
| Total assets | NOK 1,3M | +15% |
| Equity | NOK 313K | -42% |
| Employees | 0 | — |
Legal name
SILKO AS
Org number
998751608
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
27. august 2012
Share capital
NOK 30 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legetjenester. Medisinsk virksomhet. Konsulentvirksomhet. Handelsvirksomhet og andre tjenester som kjøp, salg av varer, import og eksport av varer og dertil hørende virksomhet. Investering i verdipapirer, virksomhet og eiendom samt øvrige virksomheter som faller naturlig under dette.
Address
Medical City Lørenveien 68, 0585 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 197 | 2 322 | 2 608 | 2 925 | 2 814 | 1 646 | 1 532 | 2 663 | 2 902 | 2 932 | 1 275 | 203 | 2 520 |
| Staff expenses | −0 | −0 | −15 | −66 | −569 | −710 | −565 | −757 | −681 | −84 | −0 | −0 | −5 |
| EBITDA | 654 | 1 222 | 1 278 | 945 | 385 | 18 | 362 | 53 | −175 | 240 | −870 | 203 | 1 543 |
| Depreciation & amort. | −0 | −11 | −26 | −39 | −35 | −24 | −51 | −48 | −34 | −24 | −17 | −0 | −47 |
| EBIT | 654 | 1 210 | 1 252 | 906 | 350 | −5 | 311 | 5 | −209 | 217 | −887 | 203 | 1 496 |
| Net financials | 0 | 2 | 20 | 12 | 1 | 0 | −4 | −2 | −42 | −2 | −4 | 0 | 0 |
| Profit before tax | 654 | 1 213 | 1 272 | 918 | 351 | −5 | 307 | 3 | −251 | 215 | −891 | 203 | 1 496 |
| Tax | 180 | 341 | 362 | 248 | 93 | −0 | −0 | −0 | 15 | −0 | −0 | 45 | 329 |
| Net profit | 473 | 872 | 910 | 670 | 258 | −5 | 307 | 3 | −266 | 215 | −891 | 159 | 1 167 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 726 | 1 469 | 1 565 | 1 578 | 1 379 | 1 363 | 3 592 | 2 816 | 2 702 | 2 137 | 845 | 1 087 | 1 254 |
| Equity | 93 | 105 | 1 014 | 835 | 1 092 | 1 087 | 1 322 | 1 325 | 1 059 | 1 273 | 382 | 541 | 313 |
| Long-term debt | 0 | 0 | 1 | 2 | 1 | 0 | 317 | 316 | 132 | −336 | −461 | −461 | 287 |
| Short-term debt | 633 | 1 365 | 549 | 742 | 286 | 276 | 1 953 | 1 175 | 1 511 | 1 199 | 923 | 1 007 | 654 |
| Total debt | 633 | 1 365 | 550 | 744 | 287 | 276 | 2 270 | 1 491 | 1 643 | 863 | 462 | 547 | 942 |
EBITDA margin
61.2%
This company
15.8%
Market median
+287% vs market
20122024
Equity ratio
24.9%
This company
38.2%
Market median
-35% vs market
20122024
Return on equity
373.3%
This company
18.4%
Market median
+1929% vs market
20122024
Net profit margin
46.3%
This company
8.1%
Market median
+472% vs market
20122024
Asset turnover
2.01×
This company
1.12×
Market median
+79% vs market
20122024
Debt / equity
3.01×
This company
0.62×
Market median
-385% vs market
20122024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-06-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AK Deputy Member | Deputy Member | 2012 | — | — |
OK Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SILKO AS 
Medical City AsBoard members of SILKO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Audun Karstad | Deputy Member | 0 companies |
| Olav Karstad | Chief Executive Officer | 0 companies |